Marcelo Alex de Carvalho
Overview
Explore the profile of Marcelo Alex de Carvalho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coelho L, Vianna M, da Silva D, Gonzaga B, Rodrigues Ferreira R, Monteiro A, et al.
Biology (Basel)
. 2024 Jul;
13(7).
PMID: 39056658
Breast cancer is the most prevalent cancer among women worldwide. Therapeutic strategies to control tumors and metastasis are still challenging. Three-dimensional (3D) spheroid-type systems more accurately replicate the features of...
2.
Chain M, Paiva C, Maciel I, Neto A, Castro V, Oliveira C, et al.
Exp Parasitol
. 2020 Jun;
216:107932.
PMID: 32535113
Neglected tropical diseases, such as Chagas disease caused by the protozoa Trypanosoma cruzi, affect millions of people worldwide but lack effective treatments that are accessible to the entire population, especially...
3.
Delou J, Vignal G, Indio-do-Brasil V, de Souza Accioly M, Lopes da Silva T, Piranda D, et al.
Breast Cancer (Dove Med Press)
. 2017 Jul;
9:415-428.
PMID: 28670140
gene encodes an adenosine 5'-triphosphate-binding cassette transporter, which not only confers multidrug resistance phenotype in malignant cells, but is also present in several nonmalignant tissues. For the last thirty years,...
4.
De Gregoriis G, Ramos J, Fernandes P, Vignal G, Brianese R, Carraro D, et al.
Cancer Biol Ther
. 2017 May;
18(6):439-449.
PMID: 28475402
Despite remarkable advances in diagnosis, prognosis and treatment, advanced or recurrent breast tumors have limited therapeutic approaches. Many treatment strategies try to explore the limitations of DNA damage response (DDR)...
5.
Ikemori R, Machado C, Furuzawa K, Nonogaki S, Osinaga E, Umezawa K, et al.
PLoS One
. 2014 Nov;
9(11):e111592.
PMID: 25369297
Galectin-3 (gal-3) is a β-galactoside binding protein related to many tumoral aspects, e.g. angiogenesis, cell growth and motility and resistance to cell death. Evidence has shown its upregulation upon hypoxia,...
6.
Leite M, Giacomin L, Piranda D, Festa-Vasconcellos J, Indio-do-Brasil V, Koifman S, et al.
BMC Cancer
. 2014 Mar;
14:190.
PMID: 24629097
Background: The epidermal growth factor receptor (EGFR) is differently expressed in breast cancer, and its presence may favor cancer progression. We hypothesized that two EGFR functional polymorphisms, a (CA)n repeat...